GlaxoSmithKline to Use Three Vaccine Distributors to Cover China

    Share this with colleagues:     GlaxoSmithKline signed up three companies to distribute its portfolio of vaccines in China. Each of the three companies will be responsible for a specific geographical region of the PRC. GSK is committed to offering a complete portfolio of vaccines in China, but it has recently backed away from using China partners to accomplish to develop and manufacture vaccines, preferring to depend on its own expertise. More details.... Stock Symbol: (NYSE: GSK)